The FDA Just Let ZYN Say It's the Safer Choice. Teenagers Already Decided That.
Twenty nicotine pouch products can now legally market themselves as lower-risk than cigarettes — the same week the FDA's own survey named ZYN the top pouch brand kids report using.
Twenty ZYN nicotine pouch products — ten flavors, two nicotine strengths each — can now legally tell adult smokers they’re a lower-risk choice than a cigarette. It’s the first Modified Risk Tobacco Product order the FDA has ever issued for a nicotine pouch, and it runs five years, with the agency requiring ongoing surveillance of who’s actually buying them.
The FDA is betting the claim will move adult smokers toward a safer product. The evidence so far says it’s already moved a lot of teenagers toward nicotine, period.
The order is a genuine harm-reduction argument, and it’s not a crazy one: a pouch with no combustion, no tar, no smoke, is almost certainly less dangerous than a lit cigarette, and if it pulls a pack-a-day smoker off combustibles, that’s a real public-health win worth naming plainly. That’s the case Swedish Match — the ZYN manufacturer, owned by Philip Morris International — made to get the order, and it’s the case the FDA is now letting the company print on a can.
The problem is who’s already in the market the claim is aimed at. The FDA’s own 2025 National Youth Tobacco Survey, released the same month as this order, found nicotine pouch use holding at 1.7% of middle and high schoolers — roughly 460,000 kids — with more than a quarter of them (26.3%) using pouches on at least 20 of the last 30 days, and 90.8% reaching for a flavored version, mint most popular. Asked which brand, 69.2% of those kids named ZYN specifically. That’s not a product finding an adult-smoker niche. That’s a product finding teenagers who never smoked a cigarette in their life.
The FDA can revoke the order if youth uptake climbs — that’s the safety valve built into the surveillance requirement. But a revocation is a lagging indicator. It happens after a can with a “modified risk” label has already spent months on gas-station counters at eye level for a 15-year-old, in a mint flavor the same survey shows is the one they reach for first.
If you’re the parent of a teenager, or you were one of the 460,000 yourself: the label change doesn’t mean the can got safer for you specifically. It means an adult smoker trying to quit combustibles now has a legally sanctioned reason to pick it over a pack of Marlboros — which is a different, narrower claim than “safe,” and worth knowing the difference before anyone under 21 reads the can the same way.
Sources Cited
- 01.AFDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed With a Specific Modified Risk ClaimFDA Center for Tobacco Products
- 02.A
Filed Under
policytrendsNicotineFDA
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The DEA Is About to Schedule 'Gas Station Heroin.' Kratom Itself Gets to Stay Legal.
DEA's notice of intent to schedule 7-hydroxymitragynine (7-OH) targets concentrated extracts sold as gas-station opioids, not the traditional kratom leaf — a distinction Arizona's own 'gas station heroin' crisis makes urgent.
Policy & FundingThe DEA Built a Cannabis Rescheduling Hearing Where Only One Side Gets to Talk
DEA's cannabis rescheduling hearing, running through July 15, seated only rescheduling opponents as witnesses — and the DOJ is now defending the process in court.
Policy & FundingThe Government Is Fighting a Drug-Testing Company in Court Over Whether Weed Is Still a Schedule I Drug
The DEA's cannabis rescheduling hearing must conclude by July 15, 2026. The DOJ is fighting to keep it on track against a drug-testing industry group — while new science complicates both sides of the story.